Expert Q&A Presentations

Duchenne Muscular Dystrophy – An Expanding Lifespan


Presentations


Speakers

  • John F. Brandsema, MD

    John F. Brandsema, MD

    John F. Brandsema, MD

    Assistant Professor Of Clinical Neurology

    John F. Brandsema, MD, is an assistant professor of clinical neurology at The Perelman School of Medicine, University of Pennsylvania in Philadelphia, and an attending physician in neuromuscular/ general neurology & electromyography at the Children’s Hospital of Philadelphia (CHOP). He earned his medical degree at Dalhousie University, Halifax, Nova Scotia, Canada and completed his pediatric neurology residency at The Hospital for Sick Children in Toronto, followed by the Partners Neuromuscular Fellowship at Harvard Medical School in Boston, Massachusetts. Dr Brandsema’s broad clinical and research interests is in neuromuscular diseases, with a focus in clinical trials of novel therapies for childhood neuromuscular disorders.
  • Betty Vertin

    Betty Vertin

    Betty Vertin

    Parent of Children with DMD

    Betty Vertin is a married mother of 6 who lives in Hastings, Nebraska. She has an undergraduate degree from Hastings College and a master’s degree from Doane University in Crete, Nebraska. Mrs. Vertin worked in education and with other nonprofit organizations for 10 years. After 3 of her children were diagnosed with Duchenne muscular dystrophy (DMD), her life changed. She now advocates on behalf of her children and all children living with DMD, and often writes about her family’s experiences in her blog, Weathered-Storms.
  • Richard J. Barohn, MD

    Richard J. Barohn, MD

    Richard J. Barohn, MD

    Gertrude and Dewey Ziegler Professor of Neurology

    Richard J. Barohn, MD, is the vice chancellor for research at the University of Kansas Medical Center (KUMC) in Kansas City, the Gertrude and Dewey Ziegler Professor of Neurology and University Distinguished Professor, and the president of the KUMC Research Institute. He is Director of Frontiers: University of Kansas Clinical and Translational Science Institute, where he works to accelerate clinical and translational research at KUMC, in the region, and nationally. Dr Barohn’s research focuses on myopathies, motor neuron diseases, peripheral neuropathies, and myasthenia gravis. He is the author of more than 250 articles, has mentored over 200 neurology residents and fellows, a member of numerous professional societies, and continues to see patients in the neurology clinic.
  • Kathryn R. Wagner, MD, PhD

    Kathryn R. Wagner, MD, PhD

    Kathryn R. Wagner, MD, PhD

    Professor of Pediatrics

    Kathryn R. Wagner, MD, PhD, is the director of the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute, and a professor of neurology and neuroscience at the Johns Hopkins School of Medicine in Baltimore, Maryland She received her BS from Yale University in New Haven, Connecticut, and her and MD and PhD from the Johns Hopkins School of Medicine. Dr Wagner's work focuses on muscle regeneration and therapeutic development for the muscular dystrophies. She is a scientific advisor for the FSH Society, Parent Project Muscular Dystrophy, and the TREAT-NMD Advisory Committee for Therapeutics, and is an elected member of American Society for Clinical Investigation.
  • Oscar H. Mayer, MD

    Oscar H. Mayer, MD

    Oscar H. Mayer, MD

    Associate Professor of Clinical Pediatrics

    Oscar H. Mayer, MD, is a professor of clinical pediatrics at The Perelman School of Medicine at the University of Pennsylvania in Philadelphia, an attending pulmonologist within the Division of Pulmonology at the Children’s Hospital of Philadelphia (CHOP) and is the medical director of the CHOP pulmonary function testing laboratory. He is the pulmonologist in the Neuromuscular Center and the Center for Thoracic Insufficiency Syndrome and directs the management of outpatients and inpatients. Dr Mayer’s clinical interests include managing patients with chronic respiratory failure, the pulmonary manifestations of neuromuscular disease, and assessing and managing patients with complex chest wall and spine disease. He is an active member of CHOP’s Asthma Clinical Science and Research and Group.